Skip to main content
Kimia Farma Tbk. logo

Kimia Farma Tbk. — Investor Relations & Filings

Ticker · KAEF ISIN · ID1000070303 IDX Manufacturing
Open in API
Filings indexed 9 across all filing types
Latest filing 2026-05-13 Regulatory Filings
Country ID Indonesia
Listing IDX KAEF

About Kimia Farma Tbk.

https://www.kimiafarma.co.id/

Kimia Farma Tbk. is a pharmaceutical company founded in 1817. It operates as a subsidiary of PT Bio Farma, focusing on the manufacturing, commercialization, and distribution of a wide array of pharmaceutical products. The company also functions as a healthcare provider, serving both domestic and international markets. It is recognized as a pioneering and major entity in the pharmaceutical industry.

Recent filings

Filing Released Lang Actions
Rencana Penyelenggaraan Public Expose - Tahunan
Regulatory Filings Classification · 75% confidence The document is a formal announcement by Kimia Farma Tbk describing the planned date, time, venue, and agenda for its annual Public Expose. It does not contain any financial data or detailed report content, nor is it the report itself; instead it is a notice of an upcoming event. There is no specific category for an event notice in the taxonomy, so this falls into the fallback category for general regulatory announcements.
2026-05-13 Indonesian
Penyampaian Bukti Iklan Panggilan RUPS
Regulatory Filings Classification · 80% confidence The document is a formal notice from Kimia Farma Tbk’s Corporate Secretary providing proof of the advertisement of an AGM (RUPS) call in media. It does not contain any financial data, proxy materials, or meeting results—only a regulatory announcement of the meeting call publication. There is no presentation, no results, no proxy statement; it is a general regulatory filing. Therefore, it falls into the fallback category Regulatory Filings (RNS).
2026-05-12 Indonesian
Pemanggilan Rapat Umum Pemegang Saham Tahunan
Proxy Solicitation & Information Statement Classification · 73% confidence The document is a formal invitation for the company’s Annual General Meeting of Shareholders, setting out the meeting date, record date, venue, and detailed agenda items for shareholder approval. It is sent to shareholders to inform them of the meeting and the matters on which they will vote. This aligns with the definition of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request their votes at a meeting.
2026-05-12 Indonesian
Laporan Bulanan Registrasi Pemegang Efek
Regulatory Filings Classification · 80% confidence The document is a regulatory monthly report (“Laporan Bulanan Registrasi Pemegang Efek”) containing detailed shareholding data, free float calculations, and investor classifications for April 2026. It is not an annual or quarterly financial statement but a compliance filing mandated by the exchange. It includes actual data rather than merely announcing or certifying a separate report. There is no category explicitly for monthly share register filings, so it falls under the fallback “Regulatory Filings” (RNS).
2026-05-08 Indonesian
KAEF - FY 2020 - LK Kimia Farma Konsolidasi 31 Desember 2020.pdf
Regulatory Filings
2020-12-31 Indonesian
KAEF - FY 2020 - inlineXBRL.zip
Regulatory Filings
2020-12-31 Indonesian

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.